Signum Biosciences' Debt Round

Signum Biosciences raised a round of funding on June 13, 2003.

Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…

Articles about Signum Biosciences' Debt Round: